Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Moving the gene patent debate forward

A framework for achieving compromise between industry and civil society.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Caulfield, T.A. & Gold, E.R. FORUM for Appl. Res. & Pub. Pol. 75 (Spring 2000).

  2. Gold, E.R. Nat. Biotechnol. 18, 1217–1218 (2000).

    Article  CAS  Google Scholar 

  3. Barboza, D. Monsanto faces growing skepticism on two fronts. New York Times , August 5 (1999), p. C1.

  4. Brown, P. & Vidal, J. GM investors told to sell their shares. The Guardian, August 25 (1999).

  5. Whitney, C.R. Europe loses its appetite for high-tech food. New York Times, June 27 (1999), p. D3.

  6. Gaskell, G. et al. Nat. Biotechnol. 18, 935–938 (2000).

    Article  CAS  Google Scholar 

  7. Priest, S.H. Nat. Biotechnol. 18, 939–942 (2000).

    Article  CAS  Google Scholar 

  8. Canadian Biotechnology Secretariat, Public opinion research into biotechnology issues. (Canadian Biotechnology Secretariat, Ottawa, ON; 2000).

  9. Taylor, C. The malaise of modernity. (Ananci, Concord, ON, Canada; 1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gold, E. Moving the gene patent debate forward. Nat Biotechnol 18, 1319–1320 (2000). https://doi.org/10.1038/82460

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/82460

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing